| First Author | Onishi Y | Year | 1996 |
| Journal | Biochem Biophys Res Commun | Volume | 228 |
| Issue | 1 | Pages | 7-13 |
| PubMed ID | 8912629 | Mgi Jnum | J:49527 |
| Mgi Id | MGI:1277900 | Doi | 10.1006/bbrc.1996.1609 |
| Citation | Onishi Y, et al. (1996) Molecular cloning of the genes suppressed in RVC lymphoma cells by topoisomerase inhibitors. Biochem Biophys Res Commun 228(1):7-13 |
| abstractText | Etoposide is a topoisomerase II inhibitor that induces DNA cleavable complex and has been used as an antitumor drug. We isolated two genes that were transcriptionally suppressed at an early stage of incubation in etoposide-treated RVC lymphoma cells, using modified PCR-based subtractive hybridization. Sequencing revealed that one of these genes, which was approximately 1.7 kb and which encoded a protein of 320 amino acids, was identical to hnRNP A1. The other was a novel gene of about 2.2 kb encoding a protein of 469 amino acids. These genes were also down-regulated in the cells incubated with camptothecin, a topoisomerase I inhibitor that induces DNA single strand breaks, but not in those exposed to ICRF-154, a topoisomerase II inhibitor that does not induce DNA cleavable complex formation. These results suggest that the early down-regulation of these genes contributes to the cytotoxicity of the topoisomerase inhibitors that induce DNA cleavage. |
